Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
UL-FS-49CL
CHR-2797 exerts antiproliferative effects against a range of tumor cell lines
FPH1 was suggested to be supplemented into the culture medium on day 1 and 5 at a concentration of 15-20 μM to induce functional proliferation of primary human hepatocytes in vitro
2-c]pyridin-5-yl}acetate
InChi: InChI=1S/C16H19ClN6O/c1-10(2)23-9-19-13-14(20-12-5-3-4-11(17)8-12)21-16(18-6-7-24)22-15(13)23/h3-5
Gefitinib - CAS# 184475-35-2 Size:Solid 2 mg UL-FS-49CLGefitinib, also known as ZD1839, is an anilinoquinazoline with antineoplastic activity. Gefitinib inhibits the catalytic activity of numerous tyrosine kinases including the epidermal growth factor receptor (EGFR), which may result in inhibition of tyrosine kinase dependent tumor growth. Specifically, this agent competes with the binding of ATP to the tyrosine kinase domain of EGFR, thereby inhibiting receptor autophosphorylation and resulting in
US$ 27500.00
US$ 13250.00
US$ 17500.00
US$ 17500.00
US$ 9500.00
US$ 34.00
US$ 34.00
US$ 30000.00
US$ 35.00
US$ 62500.00
US$ 67500.00
US$ 27500.00
US$ 62500.00
US$ 7500.00
US$ 60000.00
US$ 13500.00
US$ 7500.00
US$ 27500.00
US$ 55000.00